Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | Sarilumab |
Synonyms | |
Therapy Description |
Kevzara (sarilumab) is a monoclonal antibody that targets interleukin-6 receptor (IL6R), resulting in decreased downstream signaling and potentially leading to inhibition of tumor growth (Cancer Res 2012;72(8 Suppl):Abstract nr 2723). Kevzara (sarilumab) is FDA approved for use in patients with active rheumatoid arthritis (FDA.gov). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Sarilumab | Kevzara | REGN88|SAR153191 | Kevzara (sarilumab) is a monoclonal antibody that targets interleukin-6 receptor (IL6R), resulting in decreased downstream signaling and potentially leading to inhibition of tumor growth (Cancer Res 2012;72(8 Suppl):Abstract nr 2723). Kevzara (sarilumab) is FDA approved for use in patients with active rheumatoid arthritis (FDA.gov). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|